Waters Corporation builds the analytical instruments that pharmaceutical companies, research labs, and manufacturing facilities depend on to verify drug purity, detect contaminants, and meet regulatory requirements. Their liquid chromatography and mass spectrometry systems generate sensitive chemical analysis data across life sciences, materials science, and environmental testing - which means the company sits on a substantial attack surface. Over 100 countries, 7,600 employees, lab networks in hospitals and manufacturing sites, plus laboratory informatics software managing workflows and datasets that, if compromised, could corrupt assay results or expose proprietary formulations.
The threat model is operational integrity and supply chain risk. Instrument firmware, chromatography data systems like NuGenesis, and connected lab equipment represent vectors for tampering or ransomware that could halt production lines or invalidate FDA-compliant testing. The company runs enterprise tools - Ariba for procurement, CRM systems, Microsoft Teams, Smartsheet - creating the usual corporate IT exposure, but the real stakes are in the scientific instrumentation layer where data authenticity is non-negotiable and uptime directly impacts customer compliance deadlines.
Security work here means protecting both traditional enterprise infrastructure and the specialized domains where chemistry meets code: embedded systems in spectrometry hardware, software that controls instrument parameters, and informatics platforms handling terabytes of analytical results. Public company requirements (NYSE: WAT) add audit and disclosure pressures. The challenge isn't theoretical - it's keeping separation science operating globally while adversaries target pharma supply chains and research IP.
